4//SEC Filing
Cislini Jeff 4
Accession 0001610717-25-000368
CIK 0001628171other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 4:19 PM ET
Size
8.1 KB
Accession
0001610717-25-000368
Insider Transaction Report
Form 4
Cislini Jeff
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2025-10-17$36.57/sh+12,000$438,840→ 62,425 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-17−12,000→ 18,000 totalExercise: $36.57From: 2024-06-15Exp: 2030-06-16→ Common Stock (12,000 underlying) - Sale
Common Stock
2025-10-17$55.00/sh−12,000$660,000→ 50,425 total
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.
- [F2]Includes 43,910 restricted stock units.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001969082
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 4:19 PM ET
- Size
- 8.1 KB